first large study of glp-1 receptor agonists during pregnancy Should be continued into early pregnancy?⁠ ⁠ ➡️ Swipe to read the key takeaways from a recent target trial emulation on first-trimester GLP-1 receptor agonist use and Maternal cardiometabolic health and the

For example, participants in the trials reported side effects that were generally consistent with previous studies, such as gastrointestinal symptoms, which are one of the main reasons that can lead to discontinuation of the drugs

71 In addition, the length of exposure to GLP1RA could have been insufficient to detect some longerterm effects, increasing the chance of falsely negative results

This phase of growth will be shaped by rapid expansion in treatment access through private insurance and self-pay channels, increasing clinical adoption for cardiovascular risk reduction, and growing physician confidence in long-term safety profiles

doi: 10.1002/mrd.23353 218 KinnearHMTomaszewskiCEChangFLMoravekMBXuMPadmanabhanVet al

The brand's positioning is that it delivers added value through coaching, supplement access, and active lifestyle integration - whether that matches your needs depends on your situation

Gut repair with Akkermansia*